Related Experiment Video
Updated: Mar 23, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome
Fei-Xiang Wu1,2, Yan He3, Hui-Ting Di1
1Department of Anesthesiology & Intensive Care, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China.
Increasing endomorphin-2 (EM2) levels via gene therapy in the central nervous system can effectively manage morphine withdrawal symptoms. This novel approach offers a promising treatment for opioid addiction by sustaining EM2 release and reducing withdrawal syndrome.
Area of Science:
- Neuroscience
- Pharmacology
- Gene Therapy
Background:
- Opioid addiction treatment requires effective management of opioid withdrawal syndrome.
- Reduced endogenous endomorphin-2 (EM2) levels correlate with morphine dependence.
- The short half-life of EM2 limits its therapeutic potential.
Purpose of the Study:
- To engineer a sustained-release system for EM2 to treat opioid withdrawal.
- To investigate the efficacy of gene-delivered EM2 in the central nervous system.
Main Methods:
- Engineered an EM2 gene with a signal peptide for secretion.
- Utilized an adenovirus vector for gene delivery to the central nervous system.
- Administered the adenovirus vector and monitored EM2 levels in cerebrospinal fluid (CSF).
Main Results:
- Achieved sustained increase of EM2 levels in the CSF after adenovirus administration.
- Observed a significant reduction in morphine withdrawal syndrome.
- Demonstrated successful out-secretory expression of EM2.
Conclusions:
- Engineered EM2 gene therapy delivered to the central nervous system is a viable strategy for managing opioid withdrawal syndrome.
- Sustained EM2 release can counteract the effects of chronic morphine exposure.
- This approach presents a novel therapeutic avenue for opioid dependence treatment.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase